Frequently Asked Questions As of July 2026, retatrutide has completed four Phase 3 readouts: TRIUMPH-4 (28.7% weight loss in knee OA population, December 2025), TRIUMPH-1 (28.3% weight loss in 2,339 general obesity patients, May 2026), TRANSCEND-T2D-1 (-2.0% HbA1c and 16.8% weight loss in 537 T2D patients, June 2026), and the TRIUMPH-1 sleep apnea substudy (60.6% AHI reduction, June 2026)
How much is GLP-1 (Foundayo) without insurance
Microdosing GLP-1 medications is largely experimental and lacks scientific support from clinical trials
Cronk finds that the medication has also helped her scale back on alcohol, since after she started taking the GLP-1 she didnt feel great after drinking
Angiotensin II stimulates NHE3 activity by exocytic insertion of the transporter: role of PI 3-kinase
What a great experience